The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 27th 2025
Zoldonrasib, a novel oral KRAS G12D-selective inhibitor, demonstrated promising safety and early antitumor activity in patients with previously treated non–small cell lung cancer (NSCLC), offering a potential new targeted therapy for this underserved population.
Tip of the Week: HIPAA Intertwines with Myriad Aspects of Practice
July 29th 2020Practicing according to HIPAA standards, though, is not just to protect yourself legally, but it is the right thing to do by way of patient care, particularly through the ethical tenets of beneficence and patient autonomy.
Read More
Antibiotic Granted FDA Approval for Expanded Indication to Include Certain Pneumonia
June 5th 2020The combination of imipenem-cilastatin and relebactam was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.
Read More